Completed PHASE4 INTERVENTIONAL NCT00269243

Management With Accupril Post Bypass Graft

The Ischemia Management With Accupril Post Bypass Graft Via Inhibition of the coNverting Enzyme (IMAGINE) Trial

Sponsor: Montreal Heart Institute

Conditions CABG

Interventions Quinapril

Updated 5 times since 2017 Last updated: Feb 6, 2006 Started: Nov 30, 1999 Completion: May 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00269243, this PHASE4 trial focuses on CABG and remains completed. Sponsored by Montreal Heart Institute, it has been updated 5 times since 1999, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Nov 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Montreal Heart Institute
Pfizer

Data source: Montreal Heart Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.